Quick Facts: Medical Cannabis in Morocco
| Legal Status | Industrial/Medical CBD Legalised (No Patient Programme) |
|---|---|
| Medical Programme Since | 2021 (Law 13-21 for industrial/medical hemp) |
| Adult Use | Illegal (production historically tolerated in Rif region) |
| Access Type | CBD products available; no medical THC patient programme |
| Est. Monthly Cost | CBD products: MAD 200-800/month |
Overview
Morocco is the world's largest producer of cannabis resin (hashish), primarily from the Rif mountain region. In 2021, Law 13-21 partially legalised cannabis for medical, industrial and cosmetic purposes, allowing licensed cultivation and processing. However, this law created an industrial and export framework, not a domestic medical patient programme. There is no system for Moroccan patients to receive a medical cannabis prescription for THC-containing products as of 2026. CBD products derived from licensed hemp are increasingly available.
How to Access Medical Cannabis in Morocco
- Access CBD products — CBD products from licensed producers are available in pharmacies and specialist stores in Casablanca, Rabat, Marrakech and other cities. These are legal under Law 13-21 for products within approved limits.
- Consult a physician — Discuss symptom management with a physician. Doctors may recommend licensed CBD products for pain, anxiety or sleep issues within current legal constraints.
- Follow regulatory developments — Morocco's National Agency for Medicinal and Aromatic Plants (ANPMA) oversees the framework. A domestic patient programme may emerge as the licensed industry develops.
- Medical tourism for THC products — Patients requiring THC-containing medical cannabis must travel to countries with formal programmes such as Germany, Israel or the Netherlands.
Qualifying Conditions
- No formal qualifying conditions (no THC patient programme)
- CBD products for pain, anxiety, sleep, inflammation
- Research-stage: epilepsy, cancer, MS
Cost and Access Details
CBD and hemp-derived products in Morocco range from MAD 200-800 per month (approximately USD 20-80) depending on product type and dosage. These are available in licensed pharmacies and wellness stores. Full medical cannabis (THC) is not available through a domestic patient programme.